BD's Q4 Revenues Rise 5 Percent Amid Tough Market for Bioscience Products

Revenue growth for the BD Medical and BD Diagnostics segments more than offset weakness for the BD Biosciences segment.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.